The North America Heart Failure POC And LOC Devices Market would witness market growth of 15.7% CAGR during the forecast period (2023-2030).
Developing predictive modelling techniques-based decision support software to analyze the data measured by the LOC assays to enable therapy monitoring is one of the key market drivers. Also, ongoing studies on applying saliva-based nano-biochip tests for measuring myocardial infarction drive organic revenue growth. POC testing exhibits potential savings across various settings, including hospitals, general practices, and remote areas. In the US, the employment of POC devices resulted in a 20% decrease in hospital admissions to the chest pain unit, resulting in substantial savings in time and costs.
The prevalence of heart failure is on the rise, propelled by factors such as an aging population, sedentary lifestyles, and an increasing burden of cardiovascular risk factors. This case surge necessitates efficient and scalable diagnostic solutions, positioning POC and LOC devices as crucial tools in addressing this growing healthcare challenge. Timely intervention is critical in managing heart failure effectively. POC and LOC devices empower healthcare professionals to make swift decisions at the bedside, reducing the time between diagnosis and initiation of treatment. This demand for rapid interventions aligns with the capabilities of these devices, driving their adoption in clinical practice.
North America boasts a vital healthcare infrastructure with well-established healthcare systems and high accessibility to advanced medical technologies. According to the International Trade Administration, in 2022, Canada's medical device industry size was US$6.8 billion. The industry is expected to grow by 5.4% annually until 2028. In 2022, healthcare spending in Canada totaled approximately C$331 billion or C$8,563 per Canadian. Partnerships facilitate the development and commercialization of POC and LOC devices, ensuring that these technologies are aligned with the specific needs of the French healthcare industry. As a result, these aspects will boost the market growth in the coming years.
The US market dominated the North America Heart Failure POC And LOC Devices Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $70,298.4 Thousands by 2030, period. The Canada market is experiencing a CAGR of 18.3% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 17.3% during (2023 - 2030).
Based on Test Type, the market is segmented into Proteomic Testing, Metabolomic Testing, and Genomic Testing. Based on End Use, the market is segmented into Clinics, Hospitals, Laboratory, Assisted Living Healthcare Facilities, and Home. Based on Technology, the market is segmented into Microfluidics, Array-Based Systems, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Heart Failure POC And LOC Devices Market is Predict to reach $252.9 Million by 2030, at a CAGR of 16.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Siemens Healthineers AG (Siemens AG), Danaher Corporation, F. Hoffmann-La Roche Ltd., BioMerieux S.A., QuidelOrtho Corporation, Trinity Biotech Plc, Jant Pharmacal Corporation, Abaxis, Inc. (Zoetis Services LLC) and Werfen, S.A.
Scope of the Study
Market Segments Covered in the Report:
By Test Type
- Proteomic Testing
- Metabolomic Testing
- Genomic Testing
By End Use
- Clinics
- Hospitals
- Laboratory
- Assisted Living Healthcare Facilities
- Home
By Technology
- Microfluidics
- Array-Based Systems
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Siemens Healthineers AG (Siemens AG)
- Danaher Corporation
- F.Hoffmann-La Roche Ltd.
- BioMerieux S.A.
- QuidelOrtho Corporation
- Trinity Biotech Plc
- Jant Pharmacal Corporation
- Abaxis, Inc. (Zoetis Services LLC)
- Werfen, S.A.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Heart Failure POC And LOC Devices Market, by Test Type
1.4.2 North America Heart Failure POC And LOC Devices Market, by End Use
1.4.3 North America Heart Failure POC And LOC Devices Market, by Technology
1.4.4 North America Heart Failure POC And LOC Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. North America Heart Failure POC And LOC Devices Market by Test Type
4.1 North America Proteomic Testing Market by Country
4.2 North America Metabolomic Testing Market by Country
4.3 North America Genomic Testing Market by Country
Chapter 5. North America Heart Failure POC And LOC Devices Market by End Use
5.1 North America Clinics Market by Country
5.2 North America Hospitals Market by Country
5.3 North America Laboratory Market by Country
5.4 North America Assisted Living Healthcare Facilities Market by Country
5.5 North America Home Market by Country
Chapter 6. North America Heart Failure POC And LOC Devices Market by Technology
6.1 North America Microfluidics Market by Country
6.2 North America Array-Based Systems Market by Country
6.3 North America Others Market by Country
Chapter 7. North America Heart Failure POC And LOC Devices Market by Country
7.1 US Heart Failure POC And LOC Devices Market
7.1.1 US Heart Failure POC And LOC Devices Market by Test Type
7.1.2 US Heart Failure POC And LOC Devices Market by End Use
7.1.3 US Heart Failure POC And LOC Devices Market by Technology
7.2 Canada Heart Failure POC And LOC Devices Market
7.2.1 Canada Heart Failure POC And LOC Devices Market by Test Type
7.2.2 Canada Heart Failure POC And LOC Devices Market by End Use
7.2.3 Canada Heart Failure POC And LOC Devices Market by Technology
7.3 Mexico Heart Failure POC And LOC Devices Market
7.3.1 Mexico Heart Failure POC And LOC Devices Market by Test Type
7.3.2 Mexico Heart Failure POC And LOC Devices Market by End Use
7.3.3 Mexico Heart Failure POC And LOC Devices Market by Technology
7.4 Rest of North America Heart Failure POC And LOC Devices Market
7.4.1 Rest of North America Heart Failure POC And LOC Devices Market by Test Type
7.4.2 Rest of North America Heart Failure POC And LOC Devices Market by End Use
7.4.3 Rest of North America Heart Failure POC And LOC Devices Market by Technology
Chapter 8. Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 Siemens Healthineers AG (Siemens AG)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 Danaher Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 SWOT Analysis
8.4 F. Hoffmann-La Roche Ltd.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.6 SWOT Analysis
8.5 BioMerieux S.A.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.6 SWOT Analysis
8.6 QuidelOrtho Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expense
8.7 Trinity Biotech plc
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 Jant Pharmacal Corporation
8.8.1 Company Overview
8.9 Abaxis, Inc. (Zoetis Services LLC)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expenses
8.10. Werfen, S.A.
8.10.1 Company Overview
8.10.2 SWOT Analysis
TABLE 1 North America Heart Failure POC And LOC Devices Market, 2019 - 2022, USD Thousands
TABLE 2 North America Heart Failure POC And LOC Devices Market, 2023 - 2030, USD Thousands
TABLE 3 North America Heart Failure POC And LOC Devices Market by Test Type, 2019 - 2022, USD Thousands
TABLE 4 North America Heart Failure POC And LOC Devices Market by Test Type, 2023 - 2030, USD Thousands
TABLE 5 North America Proteomic Testing Market by Country, 2019 - 2022, USD Thousands
TABLE 6 North America Proteomic Testing Market by Country, 2023 - 2030, USD Thousands
TABLE 7 North America Metabolomic Testing Market by Country, 2019 - 2022, USD Thousands
TABLE 8 North America Metabolomic Testing Market by Country, 2023 - 2030, USD Thousands
TABLE 9 North America Genomic Testing Market by Country, 2019 - 2022, USD Thousands
TABLE 10 North America Genomic Testing Market by Country, 2023 - 2030, USD Thousands
TABLE 11 North America Heart Failure POC And LOC Devices Market by End Use, 2019 - 2022, USD Thousands
TABLE 12 North America Heart Failure POC And LOC Devices Market by End Use, 2023 - 2030, USD Thousands
TABLE 13 North America Clinics Market by Country, 2019 - 2022, USD Thousands
TABLE 14 North America Clinics Market by Country, 2023 - 2030, USD Thousands
TABLE 15 North America Hospitals Market by Country, 2019 - 2022, USD Thousands
TABLE 16 North America Hospitals Market by Country, 2023 - 2030, USD Thousands
TABLE 17 North America Laboratory Market by Country, 2019 - 2022, USD Thousands
TABLE 18 North America Laboratory Market by Country, 2023 - 2030, USD Thousands
TABLE 19 North America Assisted Living Healthcare Facilities Market by Country, 2019 - 2022, USD Thousands
TABLE 20 North America Assisted Living Healthcare Facilities Market by Country, 2023 - 2030, USD Thousands
TABLE 21 North America Home Market by Country, 2019 - 2022, USD Thousands
TABLE 22 North America Home Market by Country, 2023 - 2030, USD Thousands
TABLE 23 North America Heart Failure POC And LOC Devices Market by Technology, 2019 - 2022, USD Thousands
TABLE 24 North America Heart Failure POC And LOC Devices Market by Technology, 2023 - 2030, USD Thousands
TABLE 25 North America Microfluidics Market by Country, 2019 - 2022, USD Thousands
TABLE 26 North America Microfluidics Market by Country, 2023 - 2030, USD Thousands
TABLE 27 North America Array-Based Systems Market by Country, 2019 - 2022, USD Thousands
TABLE 28 North America Array-Based Systems Market by Country, 2023 - 2030, USD Thousands
TABLE 29 North America Others Market by Country, 2019 - 2022, USD Thousands
TABLE 30 North America Others Market by Country, 2023 - 2030, USD Thousands
TABLE 31 North America Heart Failure POC And LOC Devices Market by Country, 2019 - 2022, USD Thousands
TABLE 32 North America Heart Failure POC And LOC Devices Market by Country, 2023 - 2030, USD Thousands
TABLE 33 US Heart Failure POC And LOC Devices Market, 2019 - 2022, USD Thousands
TABLE 34 US Heart Failure POC And LOC Devices Market, 2023 - 2030, USD Thousands
TABLE 35 US Heart Failure POC And LOC Devices Market by Test Type, 2019 - 2022, USD Thousands
TABLE 36 US Heart Failure POC And LOC Devices Market by Test Type, 2023 - 2030, USD Thousands
TABLE 37 US Heart Failure POC And LOC Devices Market by End Use, 2019 - 2022, USD Thousands
TABLE 38 US Heart Failure POC And LOC Devices Market by End Use, 2023 - 2030, USD Thousands
TABLE 39 US Heart Failure POC And LOC Devices Market by Technology, 2019 - 2022, USD Thousands
TABLE 40 US Heart Failure POC And LOC Devices Market by Technology, 2023 - 2030, USD Thousands
TABLE 41 Canada Heart Failure POC And LOC Devices Market, 2019 - 2022, USD Thousands
TABLE 42 Canada Heart Failure POC And LOC Devices Market, 2023 - 2030, USD Thousands
TABLE 43 Canada Heart Failure POC And LOC Devices Market by Test Type, 2019 - 2022, USD Thousands
TABLE 44 Canada Heart Failure POC And LOC Devices Market by Test Type, 2023 - 2030, USD Thousands
TABLE 45 Canada Heart Failure POC And LOC Devices Market by End Use, 2019 - 2022, USD Thousands
TABLE 46 Canada Heart Failure POC And LOC Devices Market by End Use, 2023 - 2030, USD Thousands
TABLE 47 Canada Heart Failure POC And LOC Devices Market by Technology, 2019 - 2022, USD Thousands
TABLE 48 Canada Heart Failure POC And LOC Devices Market by Technology, 2023 - 2030, USD Thousands
TABLE 49 Mexico Heart Failure POC And LOC Devices Market, 2019 - 2022, USD Thousands
TABLE 50 Mexico Heart Failure POC And LOC Devices Market, 2023 - 2030, USD Thousands
TABLE 51 Mexico Heart Failure POC And LOC Devices Market by Test Type, 2019 - 2022, USD Thousands
TABLE 52 Mexico Heart Failure POC And LOC Devices Market by Test Type, 2023 - 2030, USD Thousands
TABLE 53 Mexico Heart Failure POC And LOC Devices Market by End Use, 2019 - 2022, USD Thousands
TABLE 54 Mexico Heart Failure POC And LOC Devices Market by End Use, 2023 - 2030, USD Thousands
TABLE 55 Mexico Heart Failure POC And LOC Devices Market by Technology, 2019 - 2022, USD Thousands
TABLE 56 Mexico Heart Failure POC And LOC Devices Market by Technology, 2023 - 2030, USD Thousands
TABLE 57 Rest of North America Heart Failure POC And LOC Devices Market, 2019 - 2022, USD Thousands
TABLE 58 Rest of North America Heart Failure POC And LOC Devices Market, 2023 - 2030, USD Thousands
TABLE 59 Rest of North America Heart Failure POC And LOC Devices Market by Test Type, 2019 - 2022, USD Thousands
TABLE 60 Rest of North America Heart Failure POC And LOC Devices Market by Test Type, 2023 - 2030, USD Thousands
TABLE 61 Rest of North America Heart Failure POC And LOC Devices Market by End Use, 2019 - 2022, USD Thousands
TABLE 62 Rest of North America Heart Failure POC And LOC Devices Market by End Use, 2023 - 2030, USD Thousands
TABLE 63 Rest of North America Heart Failure POC And LOC Devices Market by Technology, 2019 - 2022, USD Thousands
TABLE 64 Rest of North America Heart Failure POC And LOC Devices Market by Technology, 2023 - 2030, USD Thousands
TABLE 65 Key Information – Abbott Laboratories
TABLE 66 Key Information – Siemens Healthineers AG
TABLE 67 Key Information – Danaher Corporation
TABLE 68 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 69 Key information – BioMerieux S.A.
TABLE 70 key information – QuidelOrtho Corporation
TABLE 71 Key Information – Trinity Biotech plc
TABLE 72 Key Information – Jant Pharmacal Corporation
TABLE 73 Key Information – Abaxis, Inc.
TABLE 74 Key Information – Werfen, S.A.
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Heart Failure POC And LOC Devices Market, 2019 - 2030, USD Thousands
FIG 3 Key Factors Impacting Heart Failure POC And LOC Devices Market
FIG 4 Porter’s Five Forces Analysis - Heart Failure POC And LOC Devices Market
FIG 5 North America Heart Failure POC And LOC Devices Market share by Test Type, 2022
FIG 6 North America Heart Failure POC And LOC Devices Market share by Test Type, 2030
FIG 7 North America Heart Failure POC And LOC Devices Market by Test Type, 2019 - 2030, USD Thousands
FIG 8 North America Heart Failure POC And LOC Devices Market share by End Use, 2022
FIG 9 North America Heart Failure POC And LOC Devices Market share by End Use, 2030
FIG 10 North America Heart Failure POC And LOC Devices Market by End Use, 2019 - 2030, USD Thousands
FIG 11 North America Heart Failure POC And LOC Devices Market share by Technology, 2022
FIG 12 North America Heart Failure POC And LOC Devices Market share by Technology, 2030
FIG 13 North America Heart Failure POC And LOC Devices Market by Technology, 2019 - 2030, USD Thousands
FIG 14 North America Heart Failure POC And LOC Devices Market share by Country, 2022
FIG 15 North America Heart Failure POC And LOC Devices Market share by Country, 2030
FIG 16 North America Heart Failure POC And LOC Devices Market by Country, 2019 - 2030, USD Thousands
FIG 17 SWOT Analysis: Abbott Laboratories
FIG 18 SWOT Analysis: Siemens Healthineers AG
FIG 19 SWOT Analysis: Danaher Corporation
FIG 20 Swot Analysis: F. Hoffmann-La Roche Ltd.
FIG 21 Swot Analysis: BioMerieux S.A.
FIG 22 Swot Analysis: Trinity Biotech plc
FIG 23 Swot Analysis: Werfen, S.A.